Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening

Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening

Tirumalasetty Muni Chandra Babu,1 Aluru Rammohan,2 Vijaya Bhaskar Baki,1 Savita Devi,3 Duvvuru Gunasekar,2 Wudayagiri Rajendra1 1Bioinformatics Center, Division of Molecular Biology, Department of Zoology, 2Natural Products Division, Department of Chemistry, Sri Venkateswara University, Tirupati, A...

Full description

Bibliographic Details
Main Authors:	Babu TMC, Rammohan A, Baki VB, Devi S, Gunasekar D, Rajendra W
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-11-01
Series:	Drug Design, Development and Therapy
Subjects:	Gastric cancer Cell cycle Pharmacophore Molecular docking Molecular dynamics
Online Access:	https://www.dovepress.com/development-of-novel-her2-inhibitors-against-gastric-cancer-derived-fr-peer-reviewed-article-DDDT

Similar Items

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
by: Anushka A. Poola, et al.
Published: (2023-02-01)

Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of <i>Curcuma longa</i> as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer
by: Syeda Abida Ejaz, et al.
Published: (2023-05-01)

Cytotoxicity Of Chalcone Of Eugenia aquea Burm F. Leaves Against T47D Breast Cancer Cell Lines And Its Prediction As An Estrogen Receptor Antagonist Based On Pharmacophore-Molecular Dynamics Simulation
by: Muchtaridi M, et al.
Published: (2019-11-01)

Identification of BACE-1 Inhibitors against Alzheimer’s Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach
by: Kumarappan Chidambaram
Published: (2023-04-01)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
by: Yi Zhang, et al.
Published: (2020-09-01)

Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies
by: Patrick O. Sakyi, et al.
Published: (2023-01-01)

Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations
by: Said El Rhabori, et al.
Published: (2024-02-01)

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors
by: Yunjiang Zhou, et al.
Published: (2019-11-01)

Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
by: Syed Nasir Abbas Bukhari, et al.
Published: (2022-07-01)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
by: Mahmoud Ganji, et al.
Published: (2023-02-01)

Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry
by: Pooja Singh, et al.
Published: (2022-12-01)

Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies
by: Abdulrahim A. Alzain, et al.
Published: (2024-01-01)

Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2
by: Frangky Sangande, et al.
Published: (2020-10-01)

Hybrid Dynamic Pharmacophore Models as Effective Tools to Identify Novel Chemotypes for Anti-TB Inhibitor Design: A Case Study With Mtb-DapB
by: Chinmayee Choudhury, et al.
Published: (2020-12-01)

The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study
by: Lianxiang Luo, et al.
Published: (2022-05-01)

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
by: F. A. Dain Md Opo, et al.
Published: (2022-10-01)

Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors
by: Ying Fu, et al.
Published: (2020-08-01)

Multidimensional Criteria for Virtual Screening of PqsR Inhibitors Based on Pharmacophore, Docking, and Molecular Dynamics
by: Haichuan Xiao, et al.
Published: (2024-02-01)

mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations
by: Qiqi Huang, et al.
Published: (2023-08-01)

Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
by: Nathalie Moussa, et al.
Published: (2021-04-01)

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
by: Marwa A. Fouad, et al.
Published: (2024-02-01)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01)

Pharmacophore study, molecular docking and molecular dynamic simulation of virgin coconut oil derivatives as anti-inflammatory agent against COX-2
by: Kho Swen Jack, et al.
Published: (2022-10-01)

Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 M<sup>pro</sup>
by: Mohd Saeed, et al.
Published: (2021-03-01)

Ligand-based pharmacophore modelling in search of novel anaplastic lymphoma kinase inhibitors
by: V. Pratap Reddy Gajulapalli, et al.
Published: (2023-01-01)

Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth
by: Chia-Wei Weng, et al.
Published: (2022-03-01)

Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer’s Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches
by: Oluwafemi Adeleke Ojo, et al.
Published: (2021-04-01)

Ligand-based pharmacophore modeling, molecular docking, and molecular dynamic studies of HMG-CoA reductase inhibitors
by: Junaidin Junaidin, et al.
Published: (2022-01-01)

A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations
by: Ni Made Pitri Susanti, et al.
Published: (2021-12-01)

<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
by: Mohamed S. Alesawy, et al.
Published: (2021-10-01)

3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein
by: Yeganeh Entezari Heravi, et al.
Published: (2017-01-01)

Computer screening of peptidomimetics and small-molecule ligands of B-cell membrane proteins for therapy of Burkitt lymphoma
by: I. Demianenko, et al.
Published: (2023-11-01)

In silico identification and biochemical validation of plausible molecular targets of 4-thiazolidinone derivative Les-3833 as a potential anticancer agent
by: L. Kоbylinska, et al.
Published: (2021-04-01)

Combined Pharmacophore Modeling, 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Indolyl-aryl-sulfone Derivatives as New HIV1 Inhibitors
by: Mebarka Ouassaf, et al.
Published: (2022-06-01)

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma
by: F A Dain Md Opo, et al.
Published: (2022-10-01)

The Free Radical Scavenging Property of the Leaves, Branches, and Roots of <i>Mansoa hirsuta</i> DC: In Vitro Assessment, 3D Pharmacophore, and Molecular Docking Study
by: Patrícia e Silva Alves, et al.
Published: (2022-09-01)

Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation
by: Shaohua Xu, et al.
Published: (2024-01-01)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
by: Vikas Kumar, et al.
Published: (2022-06-01)

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
by: Yongze Yuan, et al.
Published: (2017-04-01)